The United States National Institutes of Health (NIH) is committed to setting research priorities that advance progress toward viral hepatitis elimination. In 2020, Dr. Harvey Alter, NIH researcher, was awarded the Nobel Prize in Medicine and Physiology for his contributions to the discovery of HCV, exemplifying the importance of NIH to hepatitis elimination efforts.
NIH and the Coalition for Global Hepatitis Elimination are launching a webinar series, “Moving from Hepatitis Discovery to Elimination” to highlight ongoing research that can benefit elimination efforts, support translation of research into implementation, and identify additional research needs. Register here.
Thursday, April 8th, 3-4:30 pm EST: Collaborative research on hepatitis C identification and treatment among persons who inject drugs Hosted by NIDA
Thursday, May 13th, 3-4:30 pm EST: Leaving no one behind: Research to uncover and address health disparities in hepatitis burden of disease and care Hosted by NIMDH/OAR
Additional monthly webinars on:
HCV Vaccine Development: Where do we stand?
Preventing mother to child transmission of hepatitis -Improving early detection of HCC: The quest of new biomarkers -New HCV diagnostic development -New frontiers for HBV therapy